B cell populations in the myasthenia thymus that bind Rituximab (anti-CD20)
Main Authors: | Zainudeen, Z, Attfield, K, Willcox, N, Vincent, A |
---|---|
Format: | Journal article |
Published: |
2014
|
Similar Items
-
The role of rituximab in the treatment of myasthenia gravis
by: Benveniste, O, et al.
Published: (2010) -
The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
by: Maddison, P, et al.
Published: (2011) -
Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status.
by: Leite, M, et al.
Published: (2007) -
Diverse Fab specific for acetylcholine receptor epitopes from a myasthenia gravis thymus combinatorial library.
by: Farrar, J, et al.
Published: (1997) -
CD45 and the thymus.
by: Beverley, P
Published: (1989)